Pentoxifylline Dosing and Clinical Role

Standard Dosing Regimen

• The American College of Cardiology recommends an oral administration of 400 mg three times daily with meals as the FDA-approved and guideline-recommended dose 1, 2, 3

Clinical Role and Efficacy

• Meta-analyses show that pentoxifylline results in marginal improvements, with pain-free walking distance increasing by 21-29 meters and maximal walking distance by 43-48 meters 1, 2, 3
• The American College of Cardiology/American Heart Association guidelines classify pentoxifylline as Class IIb (may be considered) with Level A evidence, but explicitly state its clinical effectiveness is "marginal and not well established" 1, 2, 3

When to Consider Pentoxifylline

• Pentoxifylline may be considered when cilostazol is contraindicated, such as in patients with heart failure of any severity 4
• Pentoxifylline may be considered when cilostazol is not tolerated, such as in patients who experience intolerable side effects 4

What NOT to Do

• The American College of Cardiology recommends against using parenteral pentoxifylline for critical limb ischemia, as it is classified as Class III (not useful) with Level B evidence 6, 7
• The American College of Cardiology recommends against considering pentoxifylline equivalent to cilostazol, as the evidence clearly demonstrates inferior efficacy 1, 2, 3, 4

Mechanism and Side Effects

• Pentoxifylline is purported to decrease blood viscosity, increase red blood cell deformability, and inhibit neutrophil adhesion 1, 2, 3
• Common adverse effects of pentoxifylline include sore throat, dyspepsia, nausea, and diarrhea 1, 2, 3

Alternative Indication: Severe Alcoholic Hepatitis

• Pentoxifylline 400 mg three times daily for 28 days may be used as an alternative to corticosteroids in severe alcoholic hepatitis when steroids are contraindicated 5